A distilled version of a clinical study report (CSR), which should be submitted to the FDA in the United States, in the case that the (failed) study is not relevant to the evaluation of product effectiveness or clinical pharmacology, but that provide information the reviewer needs to evaluate the safety data from the study (FDA).
Menu